A detailed history of Tig Advisors, LLC transactions in Catalent, Inc. stock. As of the latest transaction made, Tig Advisors, LLC holds 1,544,578 shares of CTLT stock, worth $98 Million. This represents 6.1% of its overall portfolio holdings.

Number of Shares
1,544,578
Previous 320,000 382.68%
Holding current value
$98 Million
Previous $18 Million 419.95%
% of portfolio
6.1%
Previous 1.3%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$56.16 - $60.96 $6.16 Million - $6.69 Million
109,682 Added 7.64%
1,544,578 $93.6 Million
Q2 2024

Aug 14, 2024

BUY
$53.58 - $57.02 $76.9 Million - $81.8 Million
1,434,896 New
1,434,896 $80.7 Million
Q1 2023

May 15, 2023

BUY
$45.44 - $74.26 $19.9 Million - $32.5 Million
437,909 New
437,909 $28.8 Million

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $11.4B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Tig Advisors, LLC Portfolio

Follow Tig Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tig Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tig Advisors, LLC with notifications on news.